1
|
Fučić A, Knežević J, Krasić J, Polančec D, Sinčić N, Sindičić Dessardo N, Starčević M, Guszak V, Ceppi M, Bruzzone M. Interleukin-2 gene methylation levels and interleukin-2 levels associated with environmental exposure as risk biomarkers for preterm birth. Croat Med J 2023; 64:320-328. [PMID: 37927185 PMCID: PMC10668044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2023] [Accepted: 10/30/2023] [Indexed: 11/07/2023] Open
Abstract
AIM To compare interleukin-2 levels (IL-2) and IL-2 gene site 1 methylation levels between preterm newborns (PN) and full-term newborns (FN) and investigate their association with the environmental exposure of their mothers during pregnancy. METHODS IL-2 and IL-2 gene site 1 methylation levels were assessed in 50 PN and 56 FN. Newborns' mothers filled in questionnaires about their living and occupational environments, habits, diets, and hobbies. RESULTS The mothers of PN were significantly more frequently agrarian/rural residents than the mothers of FN. PN had significantly higher IL-2 levels, and significantly lower methylation of IL-2 gene site 1 levels than FN. CONCLUSION IL-2 levels, hypomethylation of the IL-2 gene site 1, and the mother's rural residence (probably due to pesticide exposure) were predictive biomarkers for preterm birth. For the first time, we present the reference values for the methylation of IL-2 gene site 1 in PN and FN, which can be used in the clinical setting and biomonitoring.
Collapse
Affiliation(s)
- Aleksandra Fučić
- Aleksandra Fučić, Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia,
| | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Tavares A, Aimonen K, Ndaw S, Fučić A, Catalán J, Duca RC, Godderis L, Gomes BC, Janasik B, Ladeira C, Louro H, Namorado S, Nieuwenhuyse AV, Norppa H, Scheepers PTJ, Ventura C, Verdonck J, Viegas S, Wasowicz W, Santonen T, Silva MJ. HBM4EU Chromates Study-Genotoxicity and Oxidative Stress Biomarkers in Workers Exposed to Hexavalent Chromium. Toxics 2022; 10:483. [PMID: 36006162 PMCID: PMC9412464 DOI: 10.3390/toxics10080483] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Revised: 08/13/2022] [Accepted: 08/17/2022] [Indexed: 06/15/2023]
Abstract
A study was conducted within the European Human Biomonitoring Initiative (HBM4EU) to characterize occupational exposure to Cr(VI). Herein we present the results of biomarkers of genotoxicity and oxidative stress, including micronucleus analysis in lymphocytes and reticulocytes, the comet assay in whole blood, and malondialdehyde and 8-oxo-2′-deoxyguanosine in urine. Workers from several Cr(VI)-related industrial activities and controls from industrial (within company) and non-industrial (outwith company) environments were included. The significantly increased genotoxicity (p = 0.03 for MN in lymphocytes and reticulocytes; p < 0.001 for comet assay data) and oxidative stress levels (p = 0.007 and p < 0.001 for MDA and 8-OHdG levels in pre-shift urine samples, respectively) that were detected in the exposed workers over the outwith company controls suggest that Cr(VI) exposure might still represent a health risk, particularly, for chrome painters and electrolytic bath platers, despite the low Cr exposure. The within-company controls displayed DNA and chromosomal damage levels that were comparable to those of the exposed group, highlighting the relevance of considering all industry workers as potentially exposed. The use of effect biomarkers proved their capacity to detect the early biological effects from low Cr(VI) exposure, and to contribute to identifying subgroups that are at higher risk. Overall, this study reinforces the need for further re-evaluation of the occupational exposure limit and better application of protection measures. However, it also raised some additional questions and unexplained inconsistencies that need follow-up studies to be clarified.
Collapse
Affiliation(s)
- Ana Tavares
- Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal
| | - Kukka Aimonen
- Finnish Institute of Occupational Health, 00250 Helsinki, Finland
| | - Sophie Ndaw
- French National Research and Safety Institute, 54500 Vandœuvre-lès-Nancy, France
| | - Aleksandra Fučić
- Institute for Medical Research and Occupational Health, Ksaverska Cesta 2, HR-10001 Zagreb, Croatia
| | - Julia Catalán
- Finnish Institute of Occupational Health, 00250 Helsinki, Finland
- Department of Anatomy Embryology and Genetics, University of Zaragoza, 50013 Zaragoza, Spain
| | - Radu Corneliu Duca
- Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), O&N 5b, Herestraat 49, P.O. Box 952, 3000 Leuven, Belgium
- Department of Health Protection, Laboratoire National de Santé (LNS), 3555 Dudelange, Luxembourg
| | - Lode Godderis
- Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), O&N 5b, Herestraat 49, P.O. Box 952, 3000 Leuven, Belgium
- IDEWE, External Service for Prevention and Protection at Work, 3001 Heverlee, Belgium
| | - Bruno C. Gomes
- Centre for Toxicogenomics and Human Health (Toxomics), NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056 Lisbon, Portugal
| | - Beata Janasik
- Department of Environmental and Biological Monitoring, Nofer Institute of Occupational Medicine, 91348 Lodz, Poland
| | - Carina Ladeira
- HTRC—Health & Technology Research Center, ESTeSL—Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1549-020 Lisbon, Portugal
| | - Henriqueta Louro
- Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal
- Centre for Toxicogenomics and Human Health (Toxomics), NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056 Lisbon, Portugal
| | - Sónia Namorado
- Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal
| | - An Van Nieuwenhuyse
- Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), O&N 5b, Herestraat 49, P.O. Box 952, 3000 Leuven, Belgium
- Department of Health Protection, Laboratoire National de Santé (LNS), 3555 Dudelange, Luxembourg
| | - Hannu Norppa
- Finnish Institute of Occupational Health, 00250 Helsinki, Finland
| | - Paul T. J. Scheepers
- Radboud Institute for Health Sciences, Radboudumc, 6500 HB Nijmegen, The Netherlands
| | - Célia Ventura
- Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal
- Centre for Toxicogenomics and Human Health (Toxomics), NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056 Lisbon, Portugal
| | - Jelle Verdonck
- Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), O&N 5b, Herestraat 49, P.O. Box 952, 3000 Leuven, Belgium
| | - Susana Viegas
- NOVA National School of Public Health, Universidade NOVA de Lisboa, 1600-560 Lisbon, Portugal
- Comprehensive Health Research Center (CHRC), 1169-056 Lisbon, Portugal
| | - Wojciech Wasowicz
- Department of Environmental and Biological Monitoring, Nofer Institute of Occupational Medicine, 91348 Lodz, Poland
| | - Tiina Santonen
- Finnish Institute of Occupational Health, 00250 Helsinki, Finland
| | - Maria João Silva
- Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal
- Centre for Toxicogenomics and Human Health (Toxomics), NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056 Lisbon, Portugal
| | | |
Collapse
|
3
|
Marić T, Wójcik I, Katušić Bojanac A, Matijević A, Ceppi M, Bruzzone M, Evgeni E, Petrović T, Trbojević-Akmačić I, Lauc G, Ježek D, Fučić A. Seminal plasma N-glycome as a new biomarker of environmental exposure associated with semen quality. Reprod Toxicol 2022; 113:96-102. [PMID: 35961531 DOI: 10.1016/j.reprotox.2022.08.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2022] [Revised: 07/27/2022] [Accepted: 08/07/2022] [Indexed: 11/25/2022]
Abstract
Male infertility, a condition that has during the last decade raised significant concern, is a diagnostically demanding and socially sensitive topic. The number of unsolved issues on infertility etiology, especially potential environmental causes, in couples demonstrates the need for further investigations into infertility biomarkers. Semen parameters are often insufficient for reliable profiling of male infertility. Thus, this study aims to evaluate for the first time seminal plasma N-glycosylation as a biomarker of environmental exposure in semen samples from 82 normozoospermic men and 84 men with abnormal semen parameters and compare it with genome damage measured by DNA fragmentation. We obtained information about chronic exposure to environmental factors from the self-reported questionnaire, and determined sperm DNA fragmentation by sperm chromatin dispersion, while N-glycans were characterized with liquid chromatography-mass spectrometry (LC-MS). Based on previously published results, ten N-glycans were selected. Results show that the selected seminal plasma N-glycans were significantly associated with smoking, exposure to pesticides, air pollution, agents emitted during photocopying, alcohol consumption, and obesity. Some N-glycans showed a simultaneous association with DNA fragmentation, semen parameters, and environmental stressors. These subgroups of N-glycans are new potential candidates for biomonitoring of exposure to different environmental factors in men with semen abnormalities.
Collapse
Affiliation(s)
- T Marić
- Scientific Centre of Excellence for Reproductive and Regenerative Medicine, University of Zagreb School of Medicine, 10 000 Zagreb, Croatia; University of Zagreb School of Medicine, 10 000 Zagreb, Croatia.
| | - I Wójcik
- Genos Glycoscience Research Laboratory, 10 000 Zagreb, Croatia
| | - A Katušić Bojanac
- Scientific Centre of Excellence for Reproductive and Regenerative Medicine, University of Zagreb School of Medicine, 10 000 Zagreb, Croatia; University of Zagreb School of Medicine, 10 000 Zagreb, Croatia
| | - A Matijević
- University Hospital Centre Zagreb, Department of Laboratory Diagnostics, 10 000 Zagreb, Croatia
| | - M Ceppi
- Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, 16 132 Genova, Italy
| | - M Bruzzone
- Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, 16 132 Genova, Italy
| | - E Evgeni
- Cryogonia Cryopreservation Bank, 11 526 Athens, Greece
| | - T Petrović
- Genos Glycoscience Research Laboratory, 10 000 Zagreb, Croatia
| | | | - G Lauc
- Genos Glycoscience Research Laboratory, 10 000 Zagreb, Croatia; University of Zagreb, Faculty of Pharmacy and Biochemistry, 10 000 Zagreb, Croatia
| | - D Ježek
- Scientific Centre of Excellence for Reproductive and Regenerative Medicine, University of Zagreb School of Medicine, 10 000 Zagreb, Croatia; University of Zagreb School of Medicine, 10 000 Zagreb, Croatia
| | - A Fučić
- Scientific Centre of Excellence for Reproductive and Regenerative Medicine, University of Zagreb School of Medicine, 10 000 Zagreb, Croatia; Institute for Medical Research and Occupational Health, 10 000 Zagreb, Croatia
| |
Collapse
|
4
|
Vučičević Boras V, Fučić A, Baranović S, Blivajs I, Milenović M, Bišof V, Rakušić Z, Ceppi M, Bruzzone M. Environmental and behavioural head and neck cancer risk factors. Cent Eur J Public Health 2019; 27:106-109. [DOI: 10.21101/cejph.a5565] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2018] [Accepted: 04/12/2019] [Indexed: 11/15/2022]
|
5
|
Markulin D, Vojta A, Samaržija I, Gamulin M, Bečeheli I, Jukić I, Maglov Č, Zoldoš V, Fučić A. Association Between RASSF1A Promoter Methylation and Testicular Germ Cell Tumor: A Meta-analysis and a Cohort Study. Cancer Genomics Proteomics 2018; 14:363-372. [PMID: 28871003 DOI: 10.21873/cgp.20046] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2017] [Revised: 08/05/2017] [Accepted: 08/08/2017] [Indexed: 01/16/2023] Open
Abstract
BACKGROUND The RAS association domain family protein 1a (RASSF1A) is a prominent tumor suppressor gene showing altered promoter methylation in testicular germ cell tumors (TGCT). RASSF1A promoter hypermethylation might represent an early event in TGCT tumorigenesis. We investigated whether the RASSF1A promoter methylation in peripheral blood of TGCT patients can be associated with testicular cancer risk. MATERIALS AND METHODS Following a meta-analysis, we performed a cohort study including 32 testicular cancer patients and 32 healthy controls. Promoter methylation of the RASSF1A and O6-methylguanine-DNA-methyltransferase (MGMT) genes was analyzed using bisulfite pyrosequencing of DNA from peripheral blood. RESULTS Meta-analysis showed an odds ratio (OR) of 7.69 for RASSF1A promoter methylation as a risk factor for TGCT. Cohort study found altered methylation of the RASSF1A promoter in blood of TGCT patients. Methylation was higher in TGCT patients before BEP chemotherapy. CONCLUSION The meta-analysis indicates a role of the RASSF1A promoter hypermethylation from peripheral blood in TCGT. We confirmed that finding in our cohort study, which represents the first report of changed RASSF1A promoter methylation in peripheral blood TGCT.
Collapse
Affiliation(s)
- Dora Markulin
- University of Zagreb, Faculty of Science, Department of Biology, Division of Molecular Biology, Zagreb, Croatia
| | - Aleksandar Vojta
- University of Zagreb, Faculty of Science, Department of Biology, Division of Molecular Biology, Zagreb, Croatia
| | - Ivana Samaržija
- University of Zagreb, Faculty of Science, Department of Biology, Division of Molecular Biology, Zagreb, Croatia
| | - Marija Gamulin
- University Hospital Centre Zagreb, Department of Oncology, Zagreb, Croatia
| | | | - Irena Jukić
- Croatian Institute of Transfusion Medicine, Zagreb, Croatia
| | - Čedomir Maglov
- Croatian Institute of Transfusion Medicine, Zagreb, Croatia
| | - Vlatka Zoldoš
- University of Zagreb, Faculty of Science, Department of Biology, Division of Molecular Biology, Zagreb, Croatia
| | - Aleksandra Fučić
- Institute for Medical Research and Occupational Health, Zagreb, Croatia
| |
Collapse
|
6
|
Miškov S, Gjergja Juraški R, Mikula I, Bašić S, Bošnjak Pašić M, Košec V, Sabol Z, Fučić A, Sajko T, Bašić Kes V. The Croatian Model of Integrative Prospective Management of Epilepsy and Pregnancy. Acta Clin Croat 2017; 55:535-548. [PMID: 29116720 DOI: 10.20471/acc.2016.55.04.02] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Epilepsy is the most common neurological complication in pregnancy. Women
with epilepsy have a higher risk of complications in pregnancy. In Croatia, women with epilepsy are
treated by neurologists at tertiary centers according to the place of residence. We prospectively
followed-up pregnancies in women with epilepsy and healthy controls, and analyzed the factors
responsible for their delivery outcomes and development of their babies. Healthy pregnant women
had a higher level of education and economic status, but pregnant women with epilepsy took folic acid
in a higher proportion than controls, possibly due to timely preconception counseling. Complications
during pregnancy depended on the number of antiepileptic drugs and epilepsy control. We noticed
some behavioral and cognitive aspects in children exposed in utero to valproic acid, which required
follow up. The rate of congenital malformations was not increased. In conclusion, women with epilepsy
should receive preconception counseling about the risk for pregnancy, but also about the possibilities
to minimize that risk. We have introduced a model of integrative management of pregnancy
and epilepsy based on close collaboration among different clinical experts in Croatia, in order to
provide prompt counseling and timely intervention.
Collapse
Affiliation(s)
- Snježana Miškov
- Clinical Department of Neurology and Department of Gynecology and Obstetrics, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
| | - Romana Gjergja Juraški
- School of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia; Srebrnjak Children's Hospital, Zagreb, Croatia
| | | | - Silvio Bašić
- School of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia; Dubrava University Hospital, Zagreb Croatia
| | - Marija Bošnjak Pašić
- School of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek Croatia; Zagreb University Hospital Center, Clinical Department of Neurology, Zagreb, Croatia
| | - Vesna Košec
- Clinical Department of Neurology and Department of Gynecology and Obstetrics, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
| | | | | | - Tomislav Sajko
- Clinical Department of Neurosurgery, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
| | - Vanja Bašić Kes
- Clinical Department of Neurology and Department of Gynecology and Obstetrics, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
| |
Collapse
|
7
|
Martinić R, Sošić H, Turčić P, Konjevoda P, Fučić A, Stojković R, Aralica G, Gabričević M, Weitner T, Stambuk N. Hepatoprotective effects of Met-enkephalin on acetaminophen-induced liver lesions in male CBA mice. Molecules 2014; 19:11833-45. [PMID: 25105920 PMCID: PMC6270943 DOI: 10.3390/molecules190811833] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2014] [Revised: 07/22/2014] [Accepted: 07/31/2014] [Indexed: 11/16/2022] Open
Abstract
Recent histopathological investigations in patients with hepatitis suggested possible involvement of Met-enkephalin and its receptors in the pathophysiology of hepatitis. Consequently, we evaluated the potential hepatoprotective effects of this endogenous opioid pentapeptide in the experimental model of acetaminophen induced hepatotoxicity in male CBA mice. Met-enkephalin exhibited strong hepatoprotective effects in a dose of 7.5 mg/kg, which corresponds to the protective dose reported for several different animal disease models. In this group plasma alanine aminotransferase and aspartate aminotransferase enzyme activities, as well as liver necrosis score were significantly reduced in comparison to control animals treated with physiological saline (p>0.01). The specificity of the peptide hepatoprotection was investigated from the standpoint of the receptor and peptide blockade. It was concluded that Met-enkephalin effects on the liver were mediated via δ and ζ opioid receptors. Genotoxic testing of Met-enkephalin confirmed the safety of the peptide.
Collapse
Affiliation(s)
- Roko Martinić
- Department for Clinical Pathophysiology, Clinical Hospital Centre Split, Šoltanska 1, 21000 Split, Croatia.
| | - Hrvoje Sošić
- Department of Urology, University Clinical Hospital Centre Zagreb, Kišpatićeva 12, 10000 Zagreb, Croatia.
| | - Petra Turčić
- Department of Pharmacology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Domagojeva 2, 10000 Zagreb, Croatia.
| | - Paško Konjevoda
- Center for Nuclear Magnetic Resonance, Ruđer Bošković Institute, Bijenička cesta 54, 10002 Zagreb, Croatia.
| | - Aleksandra Fučić
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10001 Zagreb, Croatia.
| | - Ranko Stojković
- Division of Molecular Medicine, Ruđer Bošković Institute, Bijenička cesta 54, 10002 Zagreb, Croatia.
| | - Gorana Aralica
- University Hospital Dubrava, Avenija Gojka Šuška 6, 10000 Zagreb, Croatia.
| | - Mario Gabričević
- Department of General and Inorganic Chemistry, Faculty of Pharmacy and Biochemistry, University of Zagreb, Ante Kovačića 1, 10000 Zagreb, Croatia.
| | - Tin Weitner
- Department of General and Inorganic Chemistry, Faculty of Pharmacy and Biochemistry, University of Zagreb, Ante Kovačića 1, 10000 Zagreb, Croatia.
| | - Nikola Stambuk
- Center for Nuclear Magnetic Resonance, Ruđer Bošković Institute, Bijenička cesta 54, 10002 Zagreb, Croatia.
| |
Collapse
|
8
|
Katic J, Cemeli E, Baumgartner A, Laubenthal J, Bassano I, Stølevik SB, Granum B, Namork E, Nygaard UC, Løvik M, Leeuwen DV, Loock KV, Anderson D, Fučić A, Decordier I. Evaluation of the genotoxicity of 10 selected dietary/environmental compounds with the in vitro micronucleus cytokinesis-block assay in an interlaboratory comparison. Food Chem Toxicol 2010; 48:2612-23. [DOI: 10.1016/j.fct.2010.06.030] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2010] [Revised: 06/10/2010] [Accepted: 06/17/2010] [Indexed: 02/02/2023]
|
9
|
Fučić A, Stojkovic R, Katić J, Markovic D, Ferencic Z, Koršić M, Jazbec A, Gamulin M. Animal model for age- and sex-related genotoxicity of diethylstilbestrol. Braz J Med Biol Res 2009; 42:1090-6. [DOI: 10.1590/s0100-879x2009001100015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2009] [Accepted: 09/15/2009] [Indexed: 11/22/2022] Open
Affiliation(s)
- A. Fučić
- Institute for Medical Research and Occupational Health, Croatia
| | | | - J. Katić
- Institute for Medical Research and Occupational Health, Croatia
| | - D. Markovic
- GlaxoSmithKline Research Centre Zagreb Ltd., Croatia
| | | | | | | | | |
Collapse
|